vs
Encompass Health Corp（EHC）とフレッシュ・デルモンテ・プロデュース（FDP）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.0B、フレッシュ・デルモンテ・プロデュースの約1.5倍）。Encompass Health Corpの純利益率が高く（9.5% vs 3.2%、差は6.3%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 0.6%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-17.2M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -4.1%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
フレッシュ・デルモンテ・プロデュース社は世界をリードする垂直統合型の生鮮・カット生鮮野菜・果物、加工青果物の生産・流通・販売企業であり、ケイマン諸島ジョージタウンに登記され、米国の行政本部はフロリダ州コーラルゲーブルズのセビリアアベニュー241号に位置する。
EHC vs FDP — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $1.0B |
| 純利益 | $146.1M | $32.3M |
| 粗利率 | — | 10.4% |
| 営業利益率 | 16.7% | 4.5% |
| 純利益率 | 9.5% | 3.2% |
| 売上前年比 | 9.9% | 0.6% |
| 純利益前年比 | 20.8% | 59.1% |
| EPS（希薄化後） | $1.43 | $0.67 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.0B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.4B | $1.0B | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $1.3B | $1.1B |
| Q4 25 | $146.1M | $32.3M | ||
| Q3 25 | $126.5M | $-29.1M | ||
| Q2 25 | $142.1M | $56.8M | ||
| Q1 25 | $151.5M | $31.1M | ||
| Q4 24 | $120.9M | $20.3M | ||
| Q3 24 | $108.2M | $42.1M | ||
| Q2 24 | $114.1M | $53.6M | ||
| Q1 24 | $112.5M | $26.1M |
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | — | 9.2% | ||
| Q2 24 | — | 9.9% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | 16.7% | 4.5% | ||
| Q3 25 | 14.9% | -2.1% | ||
| Q2 25 | 16.2% | 5.8% | ||
| Q1 25 | 16.4% | 4.1% | ||
| Q4 24 | 14.3% | 3.0% | ||
| Q3 24 | 13.6% | 5.3% | ||
| Q2 24 | 14.3% | 6.0% | ||
| Q1 24 | 13.6% | 4.0% |
| Q4 25 | 9.5% | 3.2% | ||
| Q3 25 | 8.6% | -2.8% | ||
| Q2 25 | 9.7% | 4.8% | ||
| Q1 25 | 10.4% | 2.8% | ||
| Q4 24 | 8.6% | 2.0% | ||
| Q3 24 | 8.0% | 4.1% | ||
| Q2 24 | 8.8% | 4.7% | ||
| Q1 24 | 8.5% | 2.4% |
| Q4 25 | $1.43 | $0.67 | ||
| Q3 25 | $1.24 | $-0.61 | ||
| Q2 25 | $1.39 | $1.18 | ||
| Q1 25 | $1.48 | $0.64 | ||
| Q4 24 | $1.18 | $0.41 | ||
| Q3 24 | $1.06 | $0.88 | ||
| Q2 24 | $1.12 | $1.12 | ||
| Q1 24 | $1.10 | $0.55 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $35.7M |
| 総負債低いほど良い | $2.4B | $176.2M |
| 株主資本純資産 | $2.4B | $2.0B |
| 総資産 | $7.1B | $3.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.09× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $35.7M | ||
| Q3 25 | $48.7M | $97.2M | ||
| Q2 25 | $99.1M | $85.5M | ||
| Q1 25 | $95.8M | $34.4M | ||
| Q4 24 | $85.4M | $32.6M | ||
| Q3 24 | $147.8M | $50.8M | ||
| Q2 24 | $154.4M | $37.8M | ||
| Q1 24 | $134.4M | $42.2M |
| Q4 25 | $2.4B | $176.2M | ||
| Q3 25 | $2.4B | $176.7M | ||
| Q2 25 | $2.3B | $205.2M | ||
| Q1 25 | $2.3B | $237.4M | ||
| Q4 24 | $2.4B | $248.9M | ||
| Q3 24 | $2.3B | $274.8M | ||
| Q2 24 | $2.7B | $290.4M | ||
| Q1 24 | $2.7B | $405.8M |
| Q4 25 | $2.4B | $2.0B | ||
| Q3 25 | $2.4B | $2.0B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.7B | $1.9B |
| Q4 25 | $7.1B | $3.1B | ||
| Q3 25 | $6.9B | $3.1B | ||
| Q2 25 | $6.8B | $3.2B | ||
| Q1 25 | $6.6B | $3.2B | ||
| Q4 24 | $6.5B | $3.1B | ||
| Q3 24 | $6.5B | $3.2B | ||
| Q2 24 | $6.4B | $3.1B | ||
| Q1 24 | $6.2B | $3.2B |
| Q4 25 | 1.00× | 0.09× | ||
| Q3 25 | 1.01× | 0.09× | ||
| Q2 25 | 1.02× | 0.10× | ||
| Q1 25 | 1.08× | 0.12× | ||
| Q4 24 | 1.14× | 0.13× | ||
| Q3 24 | 1.20× | 0.14× | ||
| Q2 24 | 1.46× | 0.15× | ||
| Q1 24 | 1.54× | 0.21× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $10.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $-17.2M |
| FCFマージンFCF / 売上 | 7.6% | -1.7% |
| 設備投資強度設備投資 / 売上 | 14.8% | 2.8% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 0.34× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $181.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $10.9M | ||
| Q3 25 | $270.8M | $75.0M | ||
| Q2 25 | $270.2M | $113.1M | ||
| Q1 25 | $288.6M | $46.1M | ||
| Q4 24 | $278.8M | $-4.7M | ||
| Q3 24 | $267.8M | $43.5M | ||
| Q2 24 | $217.4M | $125.0M | ||
| Q1 24 | $238.8M | $18.7M |
| Q4 25 | $116.7M | $-17.2M | ||
| Q3 25 | $83.7M | $60.9M | ||
| Q2 25 | $113.3M | $101.5M | ||
| Q1 25 | $125.5M | $36.1M | ||
| Q4 24 | $80.1M | $-22.3M | ||
| Q3 24 | $120.3M | $30.1M | ||
| Q2 24 | $60.5M | $117.0M | ||
| Q1 24 | $99.4M | $6.0M |
| Q4 25 | 7.6% | -1.7% | ||
| Q3 25 | 5.7% | 6.0% | ||
| Q2 25 | 7.8% | 8.6% | ||
| Q1 25 | 8.6% | 3.3% | ||
| Q4 24 | 5.7% | -2.2% | ||
| Q3 24 | 8.9% | 3.0% | ||
| Q2 24 | 4.6% | 10.3% | ||
| Q1 24 | 7.6% | 0.5% |
| Q4 25 | 14.8% | 2.8% | ||
| Q3 25 | 12.7% | 1.4% | ||
| Q2 25 | 10.8% | 1.0% | ||
| Q1 25 | 11.2% | 0.9% | ||
| Q4 24 | 14.1% | 1.7% | ||
| Q3 24 | 10.9% | 1.3% | ||
| Q2 24 | 12.1% | 0.7% | ||
| Q1 24 | 10.6% | 1.1% |
| Q4 25 | 2.37× | 0.34× | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | 1.99× | ||
| Q1 25 | 1.90× | 1.48× | ||
| Q4 24 | 2.31× | -0.23× | ||
| Q3 24 | 2.48× | 1.03× | ||
| Q2 24 | 1.91× | 2.33× | ||
| Q1 24 | 2.12× | 0.72× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
